Artificial cells and Biomimicry cells: A Rising Star in the Fight Against Cancer
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101723 - 101723
Published: April 1, 2025
Biomimetic
Artificial
Cells
(ACs)
are
engineered
systems
that
mimic
the
properties
and
functions
of
natural
cells,
offering
significant
potential
for
biomedical
applications.
The
performance
applicability
these
synthetic
constructs
depend
on
choice
materials
fabrication
methods.
Our
review
delves
into
materials,
techniques,
diverse
applications
ACs,
emphasizing
their
transformative
impact
field
cancer
therapy
as
smart
vehicles
drug
delivery,
immune
system
stimulation,
cell
targeting
to
minimize
off-target
effects
maximizing
therapeutic
efficacy
well
in
vitro
models
research.
By
providing
a
comprehensive
overview,
we
aim
elucidate
how
cells
can
move
forward,
innovative
solutions
longstanding
challenges
treatment
opening
new
frontiers
less
toxic
options.
Language: Английский
Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101726 - 101726
Published: April 1, 2025
Language: Английский
Cell membrane derived biomimetic nanomedicine for precision delivery of traditional Chinese medicine in cancer therapy
Hang Xiao,
No information about this author
Faisal Raza,
No information about this author
Kunwei Li
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
unknown, P. 113829 - 113829
Published: May 1, 2025
Language: Английский
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
Wenjun Meng,
No information about this author
Li Huang,
No information about this author
Jia‐Min Guo
No information about this author
et al.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1549 - 1549
Published: Dec. 3, 2024
Nanodrug
delivery
systems
have
revolutionized
tumor
therapy
like
never
before.
By
overcoming
the
complexity
of
microenvironment
(TME)
and
bypassing
drug
resistance
mechanisms,
nanotechnology
has
shown
great
potential
to
improve
efficacy
reduce
toxic
side
effects.
This
review
examines
impact
TME
on
recent
advances
in
nanomedicine
overcome
this
challenge.
Characteristics
such
as
hypoxia,
acidity,
high
interstitial
pressure
significantly
effectiveness
chemotherapy
radiotherapy,
leading
increased
cells.
Then,
summarizes
innovative
nanocarrier
designs
for
these
microenvironmental
features,
including
hypoxia-sensitive
nanoparticles,
pH-responsive
carriers,
multifunctional
nanosystems
that
enable
targeted
release
improved
penetration
accumulation
tumors.
combining
with
therapeutic
strategies,
offers
a
novel
perspective
by
focusing
design
nanocarriers
interact
TME,
dimension
often
overlooked
similar
reviews.
We
highlight
dual
role
modulation,
emphasize
their
resistance,
look
at
future
research
directions.
Language: Английский